Cingulate Inc (CING)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | LAWRENCE, BRYAN JAY | Director | Stock Option (right to Buy) | Acquisition | 20,000 | 0 |
| Jul 16, 2026 | CALLAHAN, JENNIFER L. | EVP and CFO | Stock Option (right to Buy) | Acquisition | 19,800 | 0 |
| Jul 16, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Stock Option (right to Buy) | Acquisition | 197,650 | 0 |
| Jul 16, 2026 | HARGROVES, THOMAS JEFFREY | Director | Stock Option (right to Buy) | Acquisition | 20,000 | 0 |
| Jul 16, 2026 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 26,400 | 0 |
| Jul 16, 2026 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 53,600 | 0 |
| Jul 16, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Stock Option (right to Buy) | Acquisition | 53,600 | 0 |
| Jul 16, 2026 | WERTH, PETER J. | Director | Stock Option (right to Buy) | Acquisition | 20,000 | 0 |
| Jul 16, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Stock Option (right to Buy) | Acquisition | 26,400 | 0 |
| Jul 16, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Stock Option (right to Buy) | Acquisition | 97,350 | 0 |
| Jul 16, 2026 | DOWNEY, BRYAN WADE | EVP & Chief Commercial Officer | Stock Option (right to Buy) | Acquisition | 67,000 | 0 |
| Jul 16, 2026 | CALLAHAN, JENNIFER L. | EVP and CFO | Stock Option (right to Buy) | Acquisition | 40,200 | 0 |
| Jul 16, 2026 | DOWNEY, BRYAN WADE | EVP & Chief Commercial Officer | Stock Option (right to Buy) | Acquisition | 33,000 | 0 |
| Jun 30, 2026 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 3,885 | 0 |
| Mar 31, 2026 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 3,422 | 0 |
| Mar 9, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Common Stock | Disposal | 1,025 | 0 |
| Mar 9, 2026 | CALLAHAN, JENNIFER L. | EVP and CFO | Common Stock | Acquisition | 15,329 | 0 |
| Mar 9, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Common Stock | Acquisition | 6,862 | 0 |
| Mar 9, 2026 | PATEL, NILAY DAHYABHAI | EVP, CLO and CCO | Common Stock | Disposal | 2,086 | 0 |
| Mar 9, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Common Stock | Disposal | 2,959 | 0 |
| Mar 9, 2026 | PATEL, NILAY DAHYABHAI | EVP, CLO and CCO | Common Stock | Acquisition | 5,475 | 0 |
| Mar 9, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Common Stock | Acquisition | 4,526 | 0 |
| Mar 9, 2026 | CALLAHAN, JENNIFER L. | EVP and CFO | Common Stock | Disposal | 6,427 | 0 |
| Mar 9, 2026 | SILVA, RAUL R. | EVP and CSO | Common Stock | Acquisition | 4,526 | 0 |
| Mar 9, 2026 | SILVA, RAUL R. | EVP and CSO | Common Stock | Disposal | 1,828 | 0 |
| Mar 9, 2026 | HARGROVES, THOMAS JEFFREY | Director | Stock Option (right to Buy) | Acquisition | 15,000 | 0 |
| Feb 13, 2026 | HARGROVES, THOMAS JEFFREY | Director | Warrant to Purchase Common Stock | Acquisition | 77,821 | 0.1 |
| Feb 13, 2026 | HARGROVES, THOMAS JEFFREY | Director | Common Stock | Acquisition | 97,276 | 5.04 |
| Feb 6, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Warrant to Purchase Common Stock | Acquisition | 5,447 | 0.1 |
| Feb 6, 2026 | CALLAHAN, JENNIFER L. | SVP and CFO | Warrant to Purchase Common Stock | Acquisition | 3,891 | 0.1 |
| Feb 6, 2026 | WERTH, PETER J. | Director | Common Stock | Acquisition | 19,455 | 5.04 |
| Feb 6, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Warrant to Purchase Common Stock | Acquisition | 1,556 | 0.1 |
| Feb 6, 2026 | SCHAFFER, SHANE J. | Director, Chief Executive Officer | Common Stock | Acquisition | 6,809 | 5.04 |
| Feb 6, 2026 | WERTH, PETER J. | Director | Warrant to Purchase Common Stock | Acquisition | 15,564 | 0.1 |
| Feb 6, 2026 | BRAMS, MATTHEW | EVP and Chief Medical Officer | Common Stock | Acquisition | 1,946 | 5.04 |
| Feb 6, 2026 | CALLAHAN, JENNIFER L. | SVP and CFO | Common Stock | Acquisition | 4,864 | 5.04 |
| Dec 31, 2025 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 6,625 | 0 |
| Nov 3, 2025 | DOWNEY, BRYAN WADE | Chief Commercial Officer | Stock Option (right to Buy) | Acquisition | 30,000 | 0 |
| Sep 30, 2025 | SILVA, RAUL R. | EVP and CSO | Stock Option (right to Buy) | Acquisition | 7,334 | 0 |